Millennium Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.65M Buy
+14,000
New +$1.96M ﹤0.01% 4042
2025
Q1
Sell
-26,900
Closed -$3.87M 6313
2024
Q4
$3.87M Buy
26,900
+14,100
+110% +$2.02M ﹤0.01% 3056
2024
Q3
$1.9M Buy
12,800
+1,500
+13% +$215K ﹤0.01% 3744
2024
Q2
$1.42M Buy
11,300
+2,700
+31% +$423K ﹤0.01% 3818
2024
Q1
$1.58M Sell
8,600
-21,700
-72% -$4.13M ﹤0.01% 3929
2023
Q4
$5.45M Buy
30,300
+20,100
+197% +$3.13M ﹤0.01% 2715
2023
Q3
$1.62M Buy
+10,200
New +$1.67M ﹤0.01% 3757
2022
Q4
Sell
-3,000
Closed -$561K 6962
2022
Q3
$561K Sell
3,000
-2,000
-40% -$422K ﹤0.01% 4864
2022
Q2
$812K Buy
+5,000
New +$791K ﹤0.01% 4563
2021
Q4
Sell
-15,000
Closed -$4.33M 7295
2021
Q3
$4.33M Buy
+15,000
New +$3.85M ﹤0.01% 3023

Other funds holding RGEN

Millennium Management's RGEN Position: Q1 2026 in Review

Millennium Management reduced its Repligen (RGEN) stake by 97% in Q1 2026, selling an estimated $87.7M and leaving 22,461 shares worth $2.65M. The position accounts for ﹤0.01% of the portfolio, ranked #3601.

Millennium Management first reported a position in RGEN in Q2 2013 and has held it in 43 quarters since. The position peaked at $109M in Q3 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Millennium Management held 22,461 shares of Repligen worth $2.65M as of Q1 2026.
  • Millennium Management sold 628,085 Repligen shares in Q1 2026, an estimated $87.7M.
  • Repligen made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3601 holding.
  • Millennium Management first reported a position in Repligen in Q2 2013 and has held it in 43 quarters since.
  • Millennium Management's Repligen position peaked at $109M in Q3 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.